|
08:00
10:50
|
-
Vu Le ChuyenVietnam
Speaker
Recurrent UTI in FemaleBackground:
Recurrent urinary tract infections (rUTIs) in women present a significant clinical burden due to their high prevalence, impact on quality of life, and growing antibiotic resistance. Despite decades of research, prevention and long-term management remain challenging, requiring a multifaceted approach.
Objectives:
This presentation aims to provide an evidence-based update on the definition, epidemiology, risk factors, antimicrobial resistance, and prevention strategies for rUTIs in women, with special consideration of individual patient factors and emerging alternatives to antibiotic therapy.
Methods and Evidence Review:
Current literature and international guidelines were reviewed, including randomized controlled trials, meta-analyses, and consensus statements. Key studies addressed behavioral modifications, increased fluid intake, use of cranberry products, methenamine hippurate, D-mannose, vaginal estrogen therapy, and prophylactic antibiotics. Comparative effectiveness data between non-antibiotic strategies and vaccination were also examined.
Results:
Multiple non-antibiotic preventive strategies demonstrated clinically meaningful reductions in rUTI recurrence. For instance, vaginal estrogen showed a significant reduction in postmenopausal women (50% vs. 94% recurrence; p = 0.041). Methenamine and D-mannose also presented promising outcomes with fewer side effects than continuous antibiotics. Barriers to adherence and challenges in special populations (e.g., older adults) were identified as persistent obstacles to optimal management.
Conclusion:
Effective rUTI management in women requires individualized strategies that incorporate patient risk factors, antimicrobial stewardship, and evidence-based non-antibiotic therapies. Future directions include improved vaccine development and microbiome-based interventions. Enhancing patient adherence and addressing knowledge gaps will be key to reducing recurrence and improving outcomes
-
Peter LimSingapore
Moderator
Chronic Pelvic Pain in Women: Practical Guideline on Diagnostic and TreatmentCPPS is a debilitating often painful condition that requires a wholistic approach to treatment. Aim is to alleviate symptoms improve quality of life and requires a multidisciplinary approach of systematic evaluation to adopting pyschlogical counselling and judicious exhibition of drug therapy to use minimally invasive procedures or even open surgery. A practical and effective method to use will be outlined and discussed in the lecture Optimal Management of Bladder Pain SyndromeThis lecture will serve to reveal the real facts about chronic bladder pain and pelvic pain. How to identify and manage it with behavioural techniques. Nutritional manupularion. Drug ans other mis and new cutting edge bladder instillations and therapies.
Vu Le ChuyenVietnam
Moderator
Recurrent UTI in FemaleBackground:
Recurrent urinary tract infections (rUTIs) in women present a significant clinical burden due to their high prevalence, impact on quality of life, and growing antibiotic resistance. Despite decades of research, prevention and long-term management remain challenging, requiring a multifaceted approach.
Objectives:
This presentation aims to provide an evidence-based update on the definition, epidemiology, risk factors, antimicrobial resistance, and prevention strategies for rUTIs in women, with special consideration of individual patient factors and emerging alternatives to antibiotic therapy.
Methods and Evidence Review:
Current literature and international guidelines were reviewed, including randomized controlled trials, meta-analyses, and consensus statements. Key studies addressed behavioral modifications, increased fluid intake, use of cranberry products, methenamine hippurate, D-mannose, vaginal estrogen therapy, and prophylactic antibiotics. Comparative effectiveness data between non-antibiotic strategies and vaccination were also examined.
Results:
Multiple non-antibiotic preventive strategies demonstrated clinically meaningful reductions in rUTI recurrence. For instance, vaginal estrogen showed a significant reduction in postmenopausal women (50% vs. 94% recurrence; p = 0.041). Methenamine and D-mannose also presented promising outcomes with fewer side effects than continuous antibiotics. Barriers to adherence and challenges in special populations (e.g., older adults) were identified as persistent obstacles to optimal management.
Conclusion:
Effective rUTI management in women requires individualized strategies that incorporate patient risk factors, antimicrobial stewardship, and evidence-based non-antibiotic therapies. Future directions include improved vaccine development and microbiome-based interventions. Enhancing patient adherence and addressing knowledge gaps will be key to reducing recurrence and improving outcomes
-
Le Phuc LienVietnam
Speaker
Female Incontinence: What to Do When Synthetic Mid-Urethral Sling FailSurgical failure rates following midurethral sling (MUS) procedures vary widely, with reported rates ranging from approximately 8% to 57% at five years of follow-up. This variability is largely attributed to inconsistent definitions of surgical failure and a general lack of long-term follow-up data. A recent Cochrane review highlights the absence of high-quality evidence to support or refute specific management strategies for recurrent or persistent stress urinary incontinence (SUI) following failed MUS procedures.
A thorough clinical evaluation is essential and should include a detailed patient history, comprehensive physical examination, and clarification of the patient’s treatment goals. Conservative management options encompass pelvic floor physiotherapy, the use of an incontinence pessary, commercially available intravaginal devices (e.g., Uresta®, Impressa®), and pharmacologic therapy.
Minimally invasive interventions include periurethral bulking agent injections (bladder neck injections) and sling plication. Surgical alternatives involve repeat MUS—with or without removal of the existing mesh—salvage pubovaginal sling using autologous fascia, Burch colposuspension, or, in select cases, insertion of an artificial urinary sphincter.
In this article, we review the current evidence supporting each of these treatment modalities and describe the management algorithm adopted by our expert panel for patients presenting with SUI following failed midurethral sling surgery.
-
-
Peter LimSingapore
Speaker
Chronic Pelvic Pain in Women: Practical Guideline on Diagnostic and TreatmentCPPS is a debilitating often painful condition that requires a wholistic approach to treatment. Aim is to alleviate symptoms improve quality of life and requires a multidisciplinary approach of systematic evaluation to adopting pyschlogical counselling and judicious exhibition of drug therapy to use minimally invasive procedures or even open surgery. A practical and effective method to use will be outlined and discussed in the lecture Optimal Management of Bladder Pain SyndromeThis lecture will serve to reveal the real facts about chronic bladder pain and pelvic pain. How to identify and manage it with behavioural techniques. Nutritional manupularion. Drug ans other mis and new cutting edge bladder instillations and therapies.
-
-
Trieu DoUnited States
Speaker
Robotic Sacrocolpopexy and Current TrendsRobotic-assisted sacrocolpopexy (RASCP) has been widely used as a primary procedure to address apical prolapse. Despite its popularity, there are nuances to the RA SCP when the surgeons choose to perform this procedure. In this mini-lecture, we will discuss several trends of RA SCP including:
1. Multi-ports vs single port robotic approach
2. Retroperitoneal tunneling vs dissection technique
3. Total vs supracervical hysterectomy with SCP
-
-
-
Peter LimSingapore
Moderator
Chronic Pelvic Pain in Women: Practical Guideline on Diagnostic and TreatmentCPPS is a debilitating often painful condition that requires a wholistic approach to treatment. Aim is to alleviate symptoms improve quality of life and requires a multidisciplinary approach of systematic evaluation to adopting pyschlogical counselling and judicious exhibition of drug therapy to use minimally invasive procedures or even open surgery. A practical and effective method to use will be outlined and discussed in the lecture Optimal Management of Bladder Pain SyndromeThis lecture will serve to reveal the real facts about chronic bladder pain and pelvic pain. How to identify and manage it with behavioural techniques. Nutritional manupularion. Drug ans other mis and new cutting edge bladder instillations and therapies.
Vu Le ChuyenVietnam
Moderator
Recurrent UTI in FemaleBackground:
Recurrent urinary tract infections (rUTIs) in women present a significant clinical burden due to their high prevalence, impact on quality of life, and growing antibiotic resistance. Despite decades of research, prevention and long-term management remain challenging, requiring a multifaceted approach.
Objectives:
This presentation aims to provide an evidence-based update on the definition, epidemiology, risk factors, antimicrobial resistance, and prevention strategies for rUTIs in women, with special consideration of individual patient factors and emerging alternatives to antibiotic therapy.
Methods and Evidence Review:
Current literature and international guidelines were reviewed, including randomized controlled trials, meta-analyses, and consensus statements. Key studies addressed behavioral modifications, increased fluid intake, use of cranberry products, methenamine hippurate, D-mannose, vaginal estrogen therapy, and prophylactic antibiotics. Comparative effectiveness data between non-antibiotic strategies and vaccination were also examined.
Results:
Multiple non-antibiotic preventive strategies demonstrated clinically meaningful reductions in rUTI recurrence. For instance, vaginal estrogen showed a significant reduction in postmenopausal women (50% vs. 94% recurrence; p = 0.041). Methenamine and D-mannose also presented promising outcomes with fewer side effects than continuous antibiotics. Barriers to adherence and challenges in special populations (e.g., older adults) were identified as persistent obstacles to optimal management.
Conclusion:
Effective rUTI management in women requires individualized strategies that incorporate patient risk factors, antimicrobial stewardship, and evidence-based non-antibiotic therapies. Future directions include improved vaccine development and microbiome-based interventions. Enhancing patient adherence and addressing knowledge gaps will be key to reducing recurrence and improving outcomes
-
-
Vu Le ChuyenVietnam
Speaker
Recurrent UTI in FemaleBackground:
Recurrent urinary tract infections (rUTIs) in women present a significant clinical burden due to their high prevalence, impact on quality of life, and growing antibiotic resistance. Despite decades of research, prevention and long-term management remain challenging, requiring a multifaceted approach.
Objectives:
This presentation aims to provide an evidence-based update on the definition, epidemiology, risk factors, antimicrobial resistance, and prevention strategies for rUTIs in women, with special consideration of individual patient factors and emerging alternatives to antibiotic therapy.
Methods and Evidence Review:
Current literature and international guidelines were reviewed, including randomized controlled trials, meta-analyses, and consensus statements. Key studies addressed behavioral modifications, increased fluid intake, use of cranberry products, methenamine hippurate, D-mannose, vaginal estrogen therapy, and prophylactic antibiotics. Comparative effectiveness data between non-antibiotic strategies and vaccination were also examined.
Results:
Multiple non-antibiotic preventive strategies demonstrated clinically meaningful reductions in rUTI recurrence. For instance, vaginal estrogen showed a significant reduction in postmenopausal women (50% vs. 94% recurrence; p = 0.041). Methenamine and D-mannose also presented promising outcomes with fewer side effects than continuous antibiotics. Barriers to adherence and challenges in special populations (e.g., older adults) were identified as persistent obstacles to optimal management.
Conclusion:
Effective rUTI management in women requires individualized strategies that incorporate patient risk factors, antimicrobial stewardship, and evidence-based non-antibiotic therapies. Future directions include improved vaccine development and microbiome-based interventions. Enhancing patient adherence and addressing knowledge gaps will be key to reducing recurrence and improving outcomes
-
Peter LimSingapore
Speaker
Chronic Pelvic Pain in Women: Practical Guideline on Diagnostic and TreatmentCPPS is a debilitating often painful condition that requires a wholistic approach to treatment. Aim is to alleviate symptoms improve quality of life and requires a multidisciplinary approach of systematic evaluation to adopting pyschlogical counselling and judicious exhibition of drug therapy to use minimally invasive procedures or even open surgery. A practical and effective method to use will be outlined and discussed in the lecture Optimal Management of Bladder Pain SyndromeThis lecture will serve to reveal the real facts about chronic bladder pain and pelvic pain. How to identify and manage it with behavioural techniques. Nutritional manupularion. Drug ans other mis and new cutting edge bladder instillations and therapies.
-
Martin LauHong Kong, China
Speaker
Role of PTNS in Refractory OABPTNS offers a valuable treatment alternative for refractory OAB, especially in cases where traditional therapies have failed. Its role in managing OAB highlights the importance of individualized patient care and the need for innovative approaches in urology.
-
-
-
Vu Le ChuyenVietnam
Speaker
Recurrent UTI in FemaleBackground:
Recurrent urinary tract infections (rUTIs) in women present a significant clinical burden due to their high prevalence, impact on quality of life, and growing antibiotic resistance. Despite decades of research, prevention and long-term management remain challenging, requiring a multifaceted approach.
Objectives:
This presentation aims to provide an evidence-based update on the definition, epidemiology, risk factors, antimicrobial resistance, and prevention strategies for rUTIs in women, with special consideration of individual patient factors and emerging alternatives to antibiotic therapy.
Methods and Evidence Review:
Current literature and international guidelines were reviewed, including randomized controlled trials, meta-analyses, and consensus statements. Key studies addressed behavioral modifications, increased fluid intake, use of cranberry products, methenamine hippurate, D-mannose, vaginal estrogen therapy, and prophylactic antibiotics. Comparative effectiveness data between non-antibiotic strategies and vaccination were also examined.
Results:
Multiple non-antibiotic preventive strategies demonstrated clinically meaningful reductions in rUTI recurrence. For instance, vaginal estrogen showed a significant reduction in postmenopausal women (50% vs. 94% recurrence; p = 0.041). Methenamine and D-mannose also presented promising outcomes with fewer side effects than continuous antibiotics. Barriers to adherence and challenges in special populations (e.g., older adults) were identified as persistent obstacles to optimal management.
Conclusion:
Effective rUTI management in women requires individualized strategies that incorporate patient risk factors, antimicrobial stewardship, and evidence-based non-antibiotic therapies. Future directions include improved vaccine development and microbiome-based interventions. Enhancing patient adherence and addressing knowledge gaps will be key to reducing recurrence and improving outcomes
TICC - 2F 201BC
|
_285097.jpg)